Viveve Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VIVE research report →
About the company
Viveve develops and sells healthcare-focused human resources (HR) software solutions designed to streamline and unify HR operations for healthcare organizations. It offers an all-in-one platform that supports recruitment, employee management, and attendance management, aiming to reduce administrative burden and enhance the employee experience throughout their career lifecycle. The company also provides solutions specifically tailored for the healthcare and mental and behavioral health sectors.
- CEO
- Scott D. Durbin
- IPO
- 1992
- Employees
- 47
- HQ
- Englewood, CO, US
Price Chart
- Market Cap
- $2.15K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.70
- Div Yield
- 0.00%
- Gross Margin
- 9.65%
- Op Margin
- -335.40%
- Net Margin
- -342.78%
- ROE
- -199.88%
- ROIC
- -99.76%
- Revenue
- $6.43M · 17.28%
- Net Income
- $-22,027,000 · -0.51%
- EPS
- $-2.65 · 84.00%
- Op Income
- $-21,553,000
- FCF YoY
- 16.74%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -44.95
- Avg Volume
- 2.20K
Get TickerSpark's AI analysis on VIVE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 3, 23 | Basta Steven L | other | 72,000 |
| Jan 3, 23 | Durbin Scott | other | 360,000 |
| Jan 3, 23 | JORN DEBORA | other | 36,000 |
| Jan 3, 23 | Morris Arlene | other | 36,000 |
| Jan 3, 23 | Presnell Sharon Collins | other | 36,000 |
| Jan 3, 23 | Robbins Jim B | other | 57,000 |
| Jan 4, 22 | JORN DEBORA | other | 22,000 |
| Jan 4, 22 | Morris Arlene | other | 22,000 |
| Jan 4, 22 | Presnell Sharon Collins | other | 18,000 |
| Jan 4, 22 | Robbins Jim B | other | 42,000 |
Our VIVE coverage
Recent articles, reports, and earnings notes.
No research on VIVE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VIVE report →Similar companies
Peers in the same neighborhood.